This contract opportunity involves the provision of pharmaceutical billing data from mail-order pharmacies, public pharmacies, and outpatient hospital services, along with the delivery of an online analysis software. Suppliers are invited to submit proposals for the supply of these services, which a
Tender closed on 11 Aug 2025. Awaiting award.
This contract aims to establish selective discount agreements with pharmaceutical companies for the supply of finished medicinal products. These agreements will be based on active ingredients and are divided into specific lots. Detailed information can be found in the contract terms and pricing shee
This contract opportunity involves the establishment of non-exclusive discount agreements for the pharmaceutical product Abiraterone, specifically in the 500mg strength and 90 tablet pack size. Under § 130a Abs. 8 SGB V, health insurance funds and pharmaceutical companies can enter into framework di
This contract pertains to the procurement of the medicine Emcitate, as part of a framework discount agreement between health insurance companies and pharmaceutical companies. The GWQ ServicePlus AG, acting on behalf of its shareholder and client health insurance funds, is conducting a formal procure
This contract opportunity involves the establishment of non-exclusive discount agreements for the pharmaceutical product Epoetin Zeta, as permitted under Section 130a, Paragraph 8 of the German Social Code (SGB V). The GWQ ServicePlus AG, acting on behalf of health insurance companies, is seeking to
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
